Pharmaceutical Medicine is a leading journal published by SPRINGER INT PUBL AG, dedicated to the field of pharmacology and pharmaceutical sciences. With ISSN 1178-2595 and E-ISSN 1179-1993, this journal serves as an essential platform for researchers and professionals to share groundbreaking findings and advancements in medication efficacy, safety, and innovative therapeutic strategies. Recognized for its contribution to the field, Pharmaceutical Medicine holds an impressive Q2 ranking in both Pharmacology and Medical Pharmacology categories, further underscored by its competitive Scopus rankings—positioned at 100/272 (63rd percentile) in Medical Pharmacology and 156/313 (50th percentile) in Pharmacology, Toxicology, and Pharmaceutics. Although it primarily operates on a traditional subscription basis, its robust academic reputation continues to attract a diverse readership worldwide. Addressed in the United Kingdom with facilities in Switzerland, the journal publishes authoritative articles from its inception in 2000 through to 2024, making it a pivotal resource for those seeking to enhance their understanding and application of pharmacological principles in clinical practice and research.

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

The Journal of Health and Safety at Work, published by the Iranian Occupational Health Association, is a vital resource for researchers, professionals, and students engaged in the fields of occupational health, safety, and environmental management. With an ISSN of 2251-807X and E-ISSN 2383-2088, this Open Access journal has been dedicated to disseminating knowledge since 2012, ensuring that critical research is accessible to a global audience. The journal’s scope encompasses a diverse range of topics including human factors and ergonomics, safety research, and public health, with a focus on enhancing workplace safety and environmental standards. Although currently positioned in the Q4 category across various disciplines within safety and health research, the journal offers a unique platform for emerging studies and innovative practices, making it a significant contributor to the discourse in these fields. The journal's commitment to open access aligns with the growing trend of transparent scholarship, thus facilitating the sharing of vital insights to improve workplace health and safety outcomes. Researchers aiming to publish groundbreaking studies in this pivotal area will find the Journal of Health and Safety at Work an indispensable avenue for advancing knowledge and fostering professional collaboration.

DRUG SAFETY is a premier academic journal published by ADIS INT LTD, dedicated to the critical field of pharmacology and toxicology. Since its inception in 1990, the journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals by providing high-quality, peer-reviewed articles that inform and advance the understanding of drug safety and efficacy. With an impressive impact factor and its current Q1 categorization in Pharmacology across various sub-disciplines, DRUG SAFETY is ranked among the top journals in its field, reflecting its commitment to excellence in scientific research. The journal features a diverse range of studies, reviews, and case reports addressing contemporary issues in drug safety, making it an invaluable tool for academia and industry alike. Although it is not an open-access journal, the content is accessible to subscribers and institutions, ensuring that essential findings in drug safety reach the widest audience possible. As the field evolves, DRUG SAFETY remains at the forefront, driving innovation and improving regulatory practices worldwide.

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

SAFETY SCIENCE, published by Elsevier in the Netherlands, is a premier international journal dedicated to advancing the fields of safety research, public health, environmental and occupational health, and risk management. With an impressive impact factor and recognized as a Q1 journal in multiple categories for 2023, its rigorous peer-reviewed articles are essential for researchers, professionals, and students alike. The journal covers a wide range of topics designed to influence safety practices and policies globally. Although Open Access options are not available, the substantial insights provided in each issue underscore the journal's critical role in enhancing the understanding of safety and risk dynamics in a constantly evolving world. With a convergence of knowledge from the years 1991 to 2025, SAFETY SCIENCE remains at the forefront of evidence-based research, stimulating essential dialogues and innovations that shape our approach to safety in various domains.

Pharmacopidemiology and Drug Safety is a prestigious academic journal published by Wiley, dedicated to exploring the field of pharmacology and epidemiological studies since its inception in 1992. With its ISSN 1053-8569 and E-ISSN 1099-1557, the journal has achieved notable recognition, ranking Q2 in Epidemiology and Q1 in Medical Pharmacology in the 2023 category quartiles. Its Scopus rankings further enhance its reputation, placing it at 105th in the field of pharmacology and at 63rd in epidemiology, reflecting its commitment to publishing high-quality research that informs clinical practices and public health policies. Although it operates under a subscription model rather than open access, Pharmacopidemiology and Drug Safety plays a critical role in disseminating vital knowledge regarding drug safety and effectiveness, making it an essential resource for researchers, professionals, and students looking to stay at the forefront of advancements in the medical field.

OCCUPATIONAL AND ENVIRONMENTAL MEDICINE is a leading academic journal dedicated to the field of public health, with a specific emphasis on environmental and occupational health. Published by the esteemed BMJ PUBLISHING GROUP, this journal has established itself as a crucial resource for researchers, professionals, and students alike, achieving a remarkable impact factor that reflects its high-quality research contributions. With a distinguished Q1 ranking in its category and a strong position in Scopus rankings—placing it at #59 out of 665—this journal showcases top-tier studies and findings from 1994 to its anticipated convergence in 2024. Set in the United Kingdom, the journal aims to advance understanding and practices relating to health in the workplace and environmental settings, making it an indispensable platform for the dissemination of knowledge in this vital area. Although not an open-access journal, it provides a valuable repository of articles that influence policy and practice worldwide, ensuring that critical information is accessible to those dedicated to promoting safer, healthier working and living environments.

FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.